We are live on
!
Find out more
Perspective Therapeutics
CATX
CATX
138 hedge funds and large institutions have $357M invested in Perspective Therapeutics in 2026 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 42 increasing their positions, 28 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
240% more capital invested
Capital invested by funds: $105M → $357M (+$252M)
214% more call options, than puts
Call options by funds: $1.89M | Put options by funds: $603K
104% more first-time investments, than exits
New positions opened: 47 | Existing positions closed: 23
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
50% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 28
26.24% more ownership
Funds ownership: 49.21% → 75.45% (+26%)
18% more funds holding
Funds holding: 117 → 138 (+21)
Holders
138
Holders Change
+21
Holders Change %
+17.95%
% of All Funds
1.7%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.04%
New
47
Increased
42
Reduced
28
Closed
23
Calls
$1.89M
Puts
$603K
Net Calls
+$1.29M
Net Calls Change
+$1.07M
Top Buyers
| 1 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$37.6M |
| 2 |
TCM
TCG Crossover Management
Palo Alto,
California
|
+$33.4M |
| 3 |
CC
Commodore Capital
New York
|
+$26.8M |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$14.7M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$13.9M |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$6.3M |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$1.71M |
| 3 |
N
Nuveen
Charlotte,
North Carolina
|
-$1.54M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$1.12M |
| 5 |
Jane Street
New York
|
-$1.12M |
